Back to search
FDAFDA · Food and drugs·Recall number D-1098-2017

Beautipharm Body Moisturizing Balm SPF 10 (Octocrylene 4% and Octyl methoxycinnamide 4%) Body Lotion, 8.3 oz. Net. Wt. 250 ml bottle, Art. 03150 Made in Germany, Doctor Eckstein, Linde Eckstein GMBH Co. Kg, 90522 Oberasbach, Germany. UPC 4 035219 031503.

Published August 23, 2017 · Recall initiated: July 17, 2017

Summary

FDA records drug Class III recall D-1098-2017, published August 23, 2017 and initiated July 17, 2017. Recalling firm: Linde Eckstein Gmbh + Co KG; Status: Terminated; Reported quantity: 105 creams; Lot: Lot #: 201017, Exp 10/20/17; 290618, Exp 06/29/18; 040419, Exp 04/04/19. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Subpotent Drug: products are labeled as having SPF 10 protection; however, this claim cannot be 100% guaranteed.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Linde Eckstein Gmbh + Co KG
Distributor
Distributed throughout the United States
Lot
Lot #: 201017, Exp 10/20/17; 290618, Exp 06/29/18; 040419, Exp 04/04/19.
Risk classification
Class III
Area (FDA)
drug
Country
Germany

Related recalls

Questions about this recall

Was Beautipharm Body Moisturizing Balm SPF 10 (Octocrylene 4% and Octyl methoxycinnamide 4%) Body Lotion, 8.3 oz. Net. Wt. 250 ml bottle, Art. 03150 Made in Germany, Doctor Eckstein, Linde Eckstein GMBH Co. Kg, 90522 Oberasbach, Germany. UPC 4 035219 031503. recalled?

Yes. FDA published recall D-1098-2017 on August 23, 2017. Reported hazard: Subpotent Drug: products are labeled as having SPF 10 protection; however, this claim cannot be 100% guaranteed.

What should I do if I have this product?

Voluntary: Firm initiated · Letter